Presence of arachidonoyl-carnitine is associated with adverse cardiometabolic responses in hypertensive patients treated with atenolol.
Weng L, Gong Y, Culver J, Gardell SJ, Petucci C, Morse AM, Frye RF, Turner ST, Chapman A, Boerwinkle E, Gums J, Beitelshees AL, Borum PR, Johnson JA, Garrett TJ, McIntyre LM, Cooper-DeHoff RM.
Weng L, et al. Among authors: frye rf.
Metabolomics. 2016 Oct;12(10):160. doi: 10.1007/s11306-016-1098-2. Epub 2016 Sep 15.
Metabolomics. 2016.
PMID: 28217401
Free PMC article.